1. Home
  2. PAYO vs GENB Comparison

PAYO vs GENB Comparison

Compare PAYO & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Payoneer Global Inc.

PAYO

Payoneer Global Inc.

HOLD

Current Price

$7.13

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$16.47

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PAYO
GENB
Founded
2005
2018
Country
United States
United States
Employees
2540
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PAYO
GENB
Price
$7.13
$16.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$7.69
$23.20
AVG Volume (30 Days)
12.4M
886.0K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.15
N/A
Revenue Next Year
$10.28
$16.58
P/E Ratio
$30.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$11.00
52 Week High
$7.67
$17.42

Technical Indicators

Market Signals
Indicator
PAYO
GENB
Relative Strength Index (RSI) 79.66 62.89
Support Level $5.67 $11.73
Resistance Level N/A $16.75
Average True Range (ATR) 0.22 1.02
MACD 0.04 0.36
Stochastic Oscillator 97.93 78.29

Price Performance

Historical Comparison
PAYO
GENB

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: